Semnur Pharmaceuticals Inc SMNR
Trading Information
- Previous Close Price
- $0.51
- Day Range
- $0.29–0.52
- 52-Week Range
- $0.13–23.00
- Bid/Ask
- $0.25 / $0.52
- Shares Outstanding
- 230.21M
- Market Cap
- $115.10M
- Volume/Avg
- 10,485 / 6,037
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 10
- Website
- https://www.semnurpharma.com
Valuation
|
Metric
|
SMNR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SMNR
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
SMNR
Profitability
|
Metric
|
SMNR
|
|---|---|
Return on Assets (Normalized) | −750.18% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SMNR
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|V<@!@NN | LOCK|m@rP! | $132B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|$mSx<^N | LOCK|bZ<J# | $84B | |||
| Moderna Inc
MRNA
| LOCK|t&WD&s< | LOCK|Q& | $83B | |||
| argenx SE ADR
ARGX
| LOCK|&!KL@S | LOCK|lRR | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|@h&JRR | LOCK|^XR | $42B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|Y#&J!?R | LOCK|Njzn | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|>PYmjX!% | LOCK|n!%T | $29B | |||
| Incyte Corp
INCY
| LOCK|%#hMRp# | LOCK|dnj | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|!W#XQr | LOCK|%r& | $22B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|j>$&nL< | LOCK|<< | $14B |
United States